Bag and mattress or bag for preterm infants in the delivery room: The Bambino Trial
| ISRCTN | ISRCTN31707342 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN31707342 |
| Protocol serial number | N/A |
| Sponsor | The National Children's Research Centre (Ireland) |
| Funder | The National Children's Research Centre (Ireland) |
- Submission date
- 31/01/2011
- Registration date
- 03/03/2011
- Last edited
- 04/09/2013
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Neonatal Intensive Care Unit
The National Maternity Hospital
Holles Street
Dublin
2
Ireland
| codonnell@nmh.ie |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Should exothermic mattresses be used in combination with polyethylene bags to prevent heat loss in preterm infants at birth? (bag and mattress or bag in the delivery room): a randomised controlled trial |
| Study acronym | The Bambino Trial |
| Study objectives | For newborn infants less than 31 weeks nursed in polyethylene bags under radiant heat, the use of exothermic mattresses results in more infants with admission temperatures outside the normal range (core temperature 36.5 - 37.5°C). |
| Ethics approval(s) | Ethics Committee of The National Maternity Hospital, Dublin, approved on the 22nd December 2010 |
| Health condition(s) or problem(s) studied | Prematurity/prevention of hypothermia in newborns |
| Intervention | Infants in both groups will be placed in a polyethylene bag and placed under radiant heat after birth. Infants randomised to the "bag" group will receive no additional measures to provide heat. Infants randomised to "mattress group" will, in addition, be placed on an exothermic chemical mattress (TransWarmer® Infant Transport Mattress, Cooper Surgical Inc., Trumbull CT, USA) which will be activated before delivery. The primary outcome for this trial is the infant's core (rectal) temperature on admission to the neonatal intensive care unit. All infants will be followed until hospital discharge. |
| Intervention type | Other |
| Primary outcome measure(s) |
Core temperature 36.5 - 37.5°C on admission to the Neonatal Intensive Care Unit (NICU) |
| Key secondary outcome measure(s) |
1. Apgar scores at 5 and 10 minutes |
| Completion date | 30/06/2012 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Neonate |
| Sex | All |
| Target sample size at registration | 116 |
| Key inclusion criteria | Infants born at the National Maternity Hospital (NMH) at less than 31 weeks gestation by best obstetric estimate |
| Key exclusion criteria | Known congenital anomaly with an open lesion (e.g. gastroschisis or myelomeningocele) |
| Date of first enrolment | 11/01/2011 |
| Date of final enrolment | 30/06/2012 |
Locations
Countries of recruitment
- Ireland
Study participating centre
2
Ireland
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/07/2013 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |